The UK Myotonic Dystrophy Patient registry is a database of genetic and clinical information about people affected by myotonic dystrophy type 1 (DM1) and type 2 (DM2) and was established in 2012. This online patient driven registry combines patient reported outcomes with professionally entered clinical and genetic information through a secure online portal. The primary aim of the registry is to facilitate and accelerate recruitment into clinical trials and research. The registry is governed by a Steering Committee of clinicians, researchers and patient organisation representatives and receives funding and support from the Muscular Dystrophy Campaign and Myotonic Dystrophy Support Group.
The registry has successfully assisted both academic and commercial partners in planning and carrying out research. As part of the TREAT-NMD network the registry shares a core dataset with many national registries globally.
Adults and children with myotonic dystrophy confirmed by a genetic test who live in the UK join the UK Myotonic Dystrophy Patient registry. People affected by Myotonic dystrophy can register online and create an account so that they can view and update their information at any time. If a person is under 18, a parent or guardian must create an account on their behalf. You will be asked to provide personal details an information about your myotonic dystrophy and how it affects you. You will also be asked to provide detailed of the consultant (neuromuscular specialist) in charge of your care.
You can register online at www.dm-registry.org/uk or you can request a paper form by calling he number below.
For Researchers (academic and commercial)
The Registry supports and encourages applications from researchers working to improve knowledge, understanding, care and treatment of myotonic dystrophy. Research which may benefit from interactions with the registry includes but is not limited to:
The registry is a flexible research tool and can facilitate and accelerate research in a number of ways:
It is important to note that the Registry releases de-identified data only; patient identifiable data will never be released to a researcher, company or other third party.
If you are interested in using the registry using the details below as soon as possible to discuss further how the interaction could be best used to aide your research. Early contact will ensure that all approvals are met and all costs are negotiated.